Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'etoposide' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2703 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gately, S; Kerbel, R
      Antiangiogenic scheduling of lower dose cancer chemotherapy

      CANCER JOURNAL
    2. Argiris, A; Murren, JR
      Advances in chemotherapy for small cell lung cancer: Single-agent activityof newer agents

      CANCER JOURNAL
    3. Baltaci, S; Orhan, D; Turkolmez, K; Yesilli, C; Beduk, Y; Tulunay, O
      P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours

      BJU INTERNATIONAL
    4. Chen, CL; Thoen, KK; Uckun, FM
      High-performance liquid chromatographic methods for the determination of topoisomerase II inhibitors

      JOURNAL OF CHROMATOGRAPHY B
    5. Zhou, R; Frostvik-Stolt, M; Liliemark, E
      Determination of etoposide in human plasma and leukemic cells by high-performance liquid chromatography with electrochemical detection

      JOURNAL OF CHROMATOGRAPHY B
    6. Tateno, H; Kamiguchi, Y
      Meiotic stage-dependent induction of chromosome aberrations in Chinese hamster primary oocytes exposed to topoisomerase II inhibitor etoposide

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    7. Turner, SD; Wijnhoven, SWP; Tinwell, H; Lashford, LS; Rafferty, JA; Ashby, J; Vrieling, H; Fairbairn, LJ
      Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assay

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    8. Kosmas, C; Tsavaris, NB; Vadiaka, M; Chiras, T; Boletis, J; Kostakis, A
      Extragonadal seminoma after renal transplantation and immunosuppression; Treatment in the presence of renal dysfunction - A case report and literature review

      MEDICAL ONCOLOGY
    9. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Cuomo, AM; Della Cuna, FSR; Baiardi, P; Torazzo, R; Preti, P; Della Cuna, GR
      Three conventional-drug combination (ifosfamide, carboplatin, etoposide-ICE regimen) in advanced non-small cell lung cancer (NSCLC)

      JOURNAL OF CHEMOTHERAPY
    11. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    12. Nanni, L; Palomba, G; Morelli, F; Piano, A; Simeone, A; D'Alessandro, V; Sirotova, Z; Capuano, G; Rinaldi, B; Lelli, G
      Combination of paclitaxel and etoposide in the treatment of advanced non-small cell lung cancer: A phase I-II study

      JOURNAL OF CHEMOTHERAPY
    13. Stuart, MJ; Chao, NS; Horning, SJ; Wong, RM; Negrin, RS; Johnston, LJ; Shizuru, JA; Long, GD; Blume, KG; Stockerl-Goldstein, KE; Goldstein, S
      Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    14. Daniel, C; Fizazi, K; Culine, S; Zelek, L; Wibault, P; Theodore, C
      Metachronous gonadal and extragonadal primacies, or late relapse of germ cell tumor?

      UROLOGIC ONCOLOGY
    15. Jagasia, MH; Langer, CJ; Johnson, DH; Yunus, F; Rodgers, JS; Schlabach, LL; Cohen, AG; Shyr, Y; Carbone, DP; DeVore, RF
      Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study

      CLINICAL CANCER RESEARCH
    16. Kanzawa, F; Koizumi, F; Koh, Y; Nakamura, T; Tatsumi, Y; Fukumoto, H; Saijo, N; Yoshioka, T; Nishio, K
      In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction

      CLINICAL CANCER RESEARCH
    17. Yu, DY; Dahl, GVH; Shames, RS; Fisher, PG
      Weekly dosing of carboplatin increases risk of allergy in children

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    18. Goldman, SC; Bracho, F; Davenport, V; Slack, R; Areman, E; Shen, V; Lenarsky, C; Weinthal, J; Hughes, R; Cairo, MS
      Feasibility study of IL-11 and granulocyte colony-stimulating factor aftermyelosuppressive chemotherapy to mobilize peripheral blood stem cells fromheavily pretreated patients

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    19. Breitfeld, PP; Lyden, E; Raney, RB; Teot, LA; Wharam, M; Lobe, T; Crist, WM; Maurer, HM; Donaldson, SS; Ruymann, FB
      Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the Intergroup Rhabdomyosarcoma Study Group

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    20. Cairo, MS; Shen, V; Krailo, MD; Bauer, M; Miser, JS; Sato, JK; Blatt, J; Blazar, BR; Frierdich, S; Liu-Mares, W; Reaman, GH
      Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    21. Aquino, VM; Schneider, NR; Sandler, ES
      Secondary myelodysplasia with monosomy 7 arising after treatment for acutelymphoblastic leukemia in childhood

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    22. Pang, SK; Zheng, NY; Felix, CA; Scavuzzo, J; Boston, R; Blair, IA
      Simultaneous determination of etoposide and its catechol metabolite in theplasma of pediatric patients by liquid chromatography/tandem mass spectrometry

      JOURNAL OF MASS SPECTROMETRY
    23. Bafna, UD; Umadevi, K; Kumaran, C; Nagarathna, DS; Shashikala, P; Tanseem, R
      Germ cell tumors of the ovary: Is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors?

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    24. Balega, J; Ulbright, TM; Look, KY
      Coexistence of metastatic neuroendocrine carcinoma of the uterine cervix with human immunodeficiency virus infection

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    25. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    26. Airoldi, M; De Crescenzo, A; Pedani, F; Marchionatti, S; Gabriele, AM; Succo, G; Rosti, G; Bumma, C
      Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    27. Stein, RS; Wolff, SN; Greer, JP; Flexner, JM; Goodman, S; Jagasia, M; Brandt, SJ; Morgan, DS; Arrowsmith, E; McCurley, TL
      Age and cytogenetics as predictors of event free survival in patients withacute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy

      LEUKEMIA & LYMPHOMA
    28. Chen, CL; Rawwas, J; Sorrell, A; Eddy, L; Uckun, FM
      Bioavailability and pharmacokinetic features of etoposide in childhood acute lymphoblastic leukemia patients

      LEUKEMIA & LYMPHOMA
    29. Hartmann, F; Jacobs, G; Gotto, H; Schwamborn, J; Pfreundschuh, M
      Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients

      LEUKEMIA & LYMPHOMA
    30. Jourdan, E; Reiffers, J; Stoppa, AM; Sotto, JJ; Attal, M; Bouabdallaha, R; Marit, G; Fegueux, N; Boulat, O; Dastugue, N; Boiron, JM; Faberes, C; Gastaut, JA; Maraninchi, D; Blaise, D
      Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group

      LEUKEMIA & LYMPHOMA
    31. Wheeler, C; Khurshid, A; Ibrahim, J; Elias, A; Mauch, P; Ault, K; Antin, J
      Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)

      LEUKEMIA & LYMPHOMA
    32. Flechon, A; Culine, S; Droz, JP
      Intensive and timely chemotherapy, the key of success in testicular cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    33. Mitry, E; Rougier, P
      The treatment of undifferentiated neuroendocrine tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    34. Lin, DM; Chen, TY; Wang, LF; Hui, CF; Hwang, J
      Characterization of drug resistance to VM-26 in A2780 ovarian carcinoma cells

      ZOOLOGICAL STUDIES
    35. Adachi, S; Itani, Y; Ito, K; Noda, T; Shintani, M; Saito, K; Furukawa, N; Tomii, Y
      Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer

      ONCOLOGY REPORTS
    36. Bobbio-Pallavicini, E; Tacconi, F; Porta, C; Brambilla, G; Mainardi, E; Bianchessi, C; Moroni, M
      Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: A phase-II study

      ONCOLOGY REPORTS
    37. Cho, JW; Park, JC; Lee, JC; Kwon, TK; Park, JW; Baek, WK; Suh, SI; Suh, MH
      The levels of MDM2 protein are decreased by a proteasome-mediated proteolysis prior to caspase-3-dependent pRb and PARP cleavages

      JOURNAL OF KOREAN MEDICAL SCIENCE
    38. Boller, YC; Brandes, LM; Russell, RL; Lin, ZP; Patierno, SR; Kennedy, KA
      Prostaglandin A(1) inhibits stress-induced NF-kappa B activation and reverses resistance to topoisomerase II inhibitors

      ONCOLOGY RESEARCH
    39. Aparicio, T; Ducreux, M; Baudin, E; Sabourin, JC; De Baere, T; Mitry, E; Schlumberger, M; Rougier, P
      Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours

      EUROPEAN JOURNAL OF CANCER
    40. Ravaud, A; Borner, M; Schellens, JHM; Geoffrois, L; Schoffski, BP; Kroon, K; Wanders, J; Hanauske, AR; Fumoleau, P
      UFT and leucovorin in first-line chemotherapy for patients with metastaticgastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial

      EUROPEAN JOURNAL OF CANCER
    41. Ohe, Y; Yamamoto, S; Suzuki, K; Hojo, F; Kakinuma, R; Matsumoto, T; Ohmatsu, H; Nishiwaki, Y
      Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer

      EUROPEAN JOURNAL OF CANCER
    42. Dearnaley, DP; Huddart, RA; Horwich, A
      Regular review - Managing testicular cancer

      BRITISH MEDICAL JOURNAL
    43. Darling, JL; Thomas, DGT
      Response of short-term cultures derived from human malignant glioma to aziridinylbenzoquinone, etoposide and doxorubicin: an in vitro phase II trial

      ANTI-CANCER DRUGS
    44. Schellens, JHM; Planting, AST; Ma, J; Maliepaard, M; de Vos, A; Dennert, MD; Verweij, J
      Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer

      ANTI-CANCER DRUGS
    45. Martinsson, P; Liminga, G; Nygren, P; Larsson, R
      Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell line

      ANTI-CANCER DRUGS
    46. Waltmire, CN; Alberts, DS; Dorr, RT
      Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer

      ANTI-CANCER DRUGS
    47. Polee, MB; Kok, TC; Siersema, PD; Tilanus, NW; Splinter, TAW; Stoter, G; Van der Gaast, A
      Phase II study of the combination cisplatin, etoposide, 5-fluorouracil andfolinic acid in patients with advanced squamous cell carcinoma of the esophagus

      ANTI-CANCER DRUGS
    48. Jagodic, M; Cufer, T; Zakotnik, B; Cervek, J
      Selection of candidates for oral etoposide salvage chemotherapy in heavilypretreated breast cancer patients

      ANTI-CANCER DRUGS
    49. Kan, WM; Liu, YT; Hsiao, CL; Shieh, CY; Kuo, JH; Huang, JD; Su, SF
      Effect of hydroxyzine on the transport of etoposide in rat small intestine

      ANTI-CANCER DRUGS
    50. Wurthwein, G; Boos, J
      Simulation tool for schedule-dependent etoposide exposure based on pharmacokinetic findings published in the literature

      ANTI-CANCER DRUGS
    51. Crino, L; Cappuzzo, F
      Gemcitabine in the treatment of advanced non-small cell lung cancer: review of main phase II and III trials

      ANTI-CANCER DRUGS
    52. Small, EJ
      Docetaxel in prostate cancer

      ANTI-CANCER DRUGS
    53. Janicke, RU; Engels, IH; Dunkern, T; Kaina, B; Schulze-Osthoff, K; Porter, AG
      Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells

      ONCOGENE
    54. Jia, L; Patwari, Y; Srinivasula, SM; Newland, AC; Fernandes-Alnemri, T; Alnemri, ES; Kelsey, SM
      Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis

      ONCOGENE
    55. Fattman, CL; Delach, SM; Dou, QP; Johnson, DE
      Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7during etoposide-induced apoptosis

      ONCOGENE
    56. Shirafuji, T; Oka, T; Sawada, T; Tamura, K; Kishimoto, K; Yamamoto, S; Nagayasu, T; Takahashi, T; Ayabe, H
      The importance of peripheral blood leukocytes and macrophage infiltration on bronchial wall wound healing in rats treated preoperatively with anticancer agents

      SURGERY TODAY
    57. Junghanss, C; Leithauser, M; Wilhelm, S; Kleine, HD; Knopp, A; Decker, S; Alscher, A; Casper, J; Kohne, CH; Freund, M
      High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize

      ANNALS OF HEMATOLOGY
    58. Gorneva, GA; Spassovska, NC; Grancharov, KC
      Appearance of aberrant mitosis in murine leukemia cells upon combined treatment with low concentrations of cisplatin and teniposide

      ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES
    59. Yang, HL; Dong, YB; Elliott, MJ; Wong, SL; McMasters, KM
      Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells

      CANCER GENE THERAPY
    60. Huddart, RA
      ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumours (NSGCT)

      ANNALS OF ONCOLOGY
    61. Vansteenkiste, JF; Vandebroek, JE; Nackaerts, KL; Weynants, P; Valcke, YJ; Verresen, DA; Devogelaere, RC; Marien, SA; Humblet, YP; Dams, NL
      Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine

      ANNALS OF ONCOLOGY
    62. Skarlos, DV; Samantas, E; Briassoulis, E; Panoussaki, E; Pavlidis, N; Kalofonos, HP; Kardamakis, D; Tsiakopoulos, E; Kosmidis, P; Tsavdaridis, D; Tzitzikas, J; Tsekeris, P; Kouvatseas, G; Zamboglou, N; Fountzilas, G
      Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

      ANNALS OF ONCOLOGY
    63. Younes, A; Preti, HA; Hagemeister, FB; McLaughlin, P; Romaguera, JE; Rodriguez, MA; Samuels, BI; Palmer, JL; Cabanillas, F
      Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

      ANNALS OF ONCOLOGY
    64. Waldherr, C; Pless, M; Maecke, HR; Haldemann, A; Mueller-Brand, J
      The clinical value of [Y-90-DOTA]-D-Phe(1)-Tyr(3)-octreotide (Y-90-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study

      ANNALS OF ONCOLOGY
    65. Quoix, E; Breton, JL; Daniel, C; Jacoulet, P; Debieuvre, D; Paillot, N; Kessler, R; Moreau, L; Coetmeur, D; Lemarie, E; Milleron, B
      Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study

      ANNALS OF ONCOLOGY
    66. Icli, F; Akbulut, H; Dincol, D; Onur, H; Demirkazik, A; Cam, R; Cay, F; Demirci, S; Uner, A; Erekul, S
      A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer

      ANNALS OF ONCOLOGY
    67. van Putten, JWG; Kerbush, T; Smit, EF; van Rijswijk, R; Beijnen, JH; Sleijfer, DT; Groen, HJM
      Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer

      ANNALS OF ONCOLOGY
    68. Vansteenkiste, J; Gatzemeier, U; Manegold, C; Hanauske, A; Weynants, P; Bosquee, L; Blatter, J; Mansouri, K; von Pawel, J
      Gemcitabine plus etoposide in chemonaive extensive disease small-cell lungcancer: A multi-centre phase II study

      ANNALS OF ONCOLOGY
    69. Berghmans, T; Paesmans, M; Sculier, JP
      The role of cisplatin in the treatment of small-cell lung cancer?

      ANNALS OF ONCOLOGY
    70. Hirsch, FR; Osterlind, K; Jeppesen, N; Dombernowsky, P; Ingeberg, S; Sorensen, PG; Kristensen, C; Hansen, HH
      Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients

      ANNALS OF ONCOLOGY
    71. Mavroudis, D; Papadakis, E; Veslemes, M; Tsiafaki, X; Stavrakakis, J; Kouroussis, C; Kakolyris, S; Bania, E; Jordanoglou, J; Agelidou, M; Vlachonicolis, J; Georgoulias, V
      A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer

      ANNALS OF ONCOLOGY
    72. Pfreundschuh, M; Hasenclever, D; Loeffler, M; Ehninger, G; Schmitz, N; Kirchner, H; Koch, P; Lathan, B; Rueffer, U; Sextro, M; Franklin, J; Tesch, H; Diehl, V
      Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF

      ANNALS OF ONCOLOGY
    73. Arija, JAA; del Muro, XG; Guma, J; Aparicio, J; Salazar, R; Saenz, A; Carles, J; Sanchez, M; Germa-Lluch, JR
      E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: The SpanishGerm Cell Cancer Group experience

      ANNALS OF ONCOLOGY
    74. Saghatchian, M; Fizazi, K; Borel, C; Ducreux, M; Ruffie, P; Le Chevalier, T; Theodore, C
      Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study

      ANNALS OF ONCOLOGY
    75. van der Lee, I; Smit, EF; van Putten, JWG; Groen, HJM; Schlosser, NJJ; Postmus, PE; Schramel, FMNH
      Single-agent gemcitabine in patients with resistant small-cell lung cancer

      ANNALS OF ONCOLOGY
    76. Langer, SW; Sehested, M; Jensen, PB
      Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice

      ANNALS OF ONCOLOGY
    77. Gilbert, MR
      Neuro-oncology clinical trials: Promise and pitfalls

      ANNALS OF ONCOLOGY
    78. Kakolyris, S; Mavroudis, D; Tsavaris, N; Souglakos, J; Tsiafaki, P; Kalbakis, K; Agelaki, S; Androulakis, N; Georgoulias, V
      Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study

      ANNALS OF ONCOLOGY
    79. Huisman, C; Postmus, PE; Giaccone, G; Smit, EF
      A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients

      ANNALS OF ONCOLOGY
    80. Bunn, PA
      Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lungcancer patients: An EORTC double-blind placebo-controlled phase III study'

      ANNALS OF ONCOLOGY
    81. Ridwelski, K; Gebauer, T; Fahlke, J; Kroning, H; Kettner, E; Meyer, F; Eichelmann, K; Lippert, H
      Combination chemotherapy with docetaxel and cisplatin for locally advancedand metastatic gastric cancer

      ANNALS OF ONCOLOGY
    82. Gridelli, C; Perrone, F; Nelli, F; Ramponi, S; De Marinis, F
      Quality of life in lung cancer patients

      ANNALS OF ONCOLOGY
    83. Sakurai, Y; Onishi, Y; Tanimoto, Y; Kizaki, H
      Novel protein kinase C delta isoform insensitive to caspase-3

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    84. Matsui, K; Masuda, N; Yana, T; Takada, Y; Kobayashi, M; Nitta, T; Hirashima, T; Fukuoka, M
      Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer

      INTERNAL MEDICINE
    85. Matsumoto, Y; Takano, H; Nagao, S; Fojo, T
      Altered topoisomerase II alpha and multidrug resistance-associated proteinlevels during drug selection: Adaptations to increasing drug pressure

      JAPANESE JOURNAL OF CANCER RESEARCH
    86. Matsumoto, Y; Takano, H; Kunishio, K; Nagao, S; Fojo, T
      Hypophosphorylation of topoisomerase II alpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation

      JAPANESE JOURNAL OF CANCER RESEARCH
    87. Shinoura, N; Sakurai, S; Asai, A; Kirino, T; Hamada, H
      Co-transduction of Apaf-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    88. Minami, H; Sasaki, Y; Watanabe, T; Ogawa, M
      Pharmacodynamic modeling of the entire time course of leukopenia after a 3-hour infusion of paclitaxel

      JAPANESE JOURNAL OF CANCER RESEARCH
    89. Matsumoto, M; Takeda, Y; Maki, H; Hojo, K; Wada, T; Nishitani, Y; Maekawa, R; Yoshioka, T
      Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    90. Proctor, SJ; Taylor, PRA; Angus, B; Wood, K; Lennard, AL; Lucraft, H; Carey, PJ; Stark, A; Iqbal, A; Haynes, A; Russel, N; Leonard, RCF; Culligan, D; Conn, J; Jackson, GH
      High-dose ifosfamide in combination with etoposide and epirubicin (IVE) inthe treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy

      EUROPEAN JOURNAL OF HAEMATOLOGY
    91. Reiser, M; Bredenfeld, H; Engert, A; Diehl, V
      The role of ifosfamide in the treatment of relapsed and refractory lymphoma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    92. Kingreen, D; Beyer, J; Kleiner, S; Reif, S; Huhn, D; Siegert, W
      ICE - an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    93. Gandara, DR; Edelman, MJ; Lara, PN; Lau, DHM
      Gemcitabine in combination with new platinum compounds: An update

      ONCOLOGY-NEW YORK
    94. Natale, RB
      Gemcitabine and nonplatinum combinations in non-small-cell Lung cancer

      ONCOLOGY-NEW YORK
    95. Curran, WJ; Choy, H
      Optimizing chemoradiation in locally advanced non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    96. Culic, S; Jakobson, A; Culic, V; Kuzmic, I; Scukanec-Spoljar, M; Primorac, D
      Etoposide as the basic and interferon-alpha as the maintenance therapy forLangerhans cell histiocytosis: A rtc

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    97. Razzouk, BI; Raimondi, SC; Srivastava, DK; Pritchard, M; Behm, FG; Tong, X; Sandlund, JT; Rubnitz, JE; Pui, CH; Ribeiro, RC
      Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience

      LEUKEMIA
    98. Karp, JE
      MDR modulation in acute myelogenous leukemia: is it dead?

      LEUKEMIA
    99. Custodio, JBA; Cardoso, CMP; Madeira, VMC; Almeida, LM
      Mitochondrial permeability transition induced by the anticancer drug etoposide

      TOXICOLOGY IN VITRO
    100. Lavicka, J; Sarissky, M; Mirossay, A; Sulla, I; Mojzis, J; Mirossay, L
      Diazepam enhances etoposide-induced cytotoxicity in U-87 MG human glioma cell line

      FUNDAMENTAL & CLINICAL PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 02:44:27